<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>modification_summary_a_037.html</title>
</head>
<body>
<p>* A new &quot;Next Level&quot; corporate strategy was introduced to accelerate growth and profitability.</p>
<p>* New operational initiatives like the JBT Excellence Model (JEM) were introduced.</p>
<p>* Acquisitions are now identified as an integral part of the company&#x27;s growth strategy.</p>
<p>* The company completed three acquisitions in its protein and liquid foods portfolios.</p>
<p>* A new disclosure was added to present and explain non-GAAP financial measures.</p>
<p>* Financial performance is now explained by investments in the new strategic initiatives.</p>
<p>* The definition of segment operating profit was revised to include currency effects.</p>
<p>* FoodTech business lines were re-categorized into &quot;protein processing&quot; and &quot;liquid foods&quot;.</p>
<p>* AeroTech product lines were re-categorized into &quot;fixed equipment&quot; and &quot;mobile equipment&quot;.</p>
<p>* Order activity slowed for protein processing in Asian markets.</p>
<p>* An acquisition is now cited as a driver for liquid foods backlog.</p>
<p>* Specific EPS guidance for the upcoming year was provided.</p>
<p>* The unfavorable impact of foreign currency translation was quantified in the outlook.</p>
<p>* A target range for segment operating margin expansion was disclosed.</p>
<p>* New &quot;Next Level&quot; operational initiatives were introduced to drive benefits.</p>
<p>* The company entered into a new, larger revolving credit facility post-year-end.</p>
<p>* The new credit facility adds borrowing capability in The Netherlands.</p>
<p>* The existing share repurchase program was extended by one year.</p>
<p>* A change in mortality assumptions increased the pension benefit obligation.</p>
<p>* Significant cash was spent on acquisitions, a change from the prior year.</p>
<p>* The company borrowed funds specifically to finance acquisitions.</p>
<p>* A plan to repay senior unsecured notes was disclosed.</p>
<p>* The Brazilian subsidiary entered into an additional, higher-interest loan.</p>
<p>* A new disclosure on a future revenue recognition standard was added.</p>
<p>* The number of Chinese subsidiaries with credit facilities has increased.</p>
<p>* A maturity date for Chinese credit facilities is now disclosed.</p>
<p>* The calculation of the EBITDA interest coverage ratio covenant was modified.</p>
<p>* The calculation of indebtedness for the leverage ratio covenant was changed.</p>
<p>* A future change to the maximum leverage ratio covenant was disclosed.</p>
<p>* A prior-year disclosure on unusually high healthcare claims was removed.</p>
<p>* Specific commentary on the deferred tax valuation allowance was removed.</p>
<p>* The expected rate of return assumption for pension assets was lowered.</p>
<p>* The disclosed sensitivity of pension obligations to discount rates has increased.</p>
</body>
</html>
